ANAVEX LIFE SCIENCES CORP. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.085 USD | -3.43% |
|
-6.95% | -56.12% |
Chart calendar Anavex Life Sciences Corp.
9258632.Rruh688sdwflc1JXMfzRHruAVaSpZaO7QtbsVr3-li0.CdaTh6ZlQ2PREiZ6UoijW_HLOeHxFunJKK-vO_uU3mEE6tWko24jX6QqFw~39618e6e90b284246c74c6fbace37b73
Upcoming events on Anavex Life Sciences Corp.
Past events on Anavex Life Sciences Corp.
| 2024-04-08 08:45 am | Needham Healthcare Conference |
| 2024-03-04 01:30 pm | TD Cowen Health Care Conference |
| 2024-02-07 08:30 am | Q1 2024 Earnings Call |
| 2024-02-07 07:30 am | Q1 2024 Earnings Release |
| 2024-01-11 01:30 pm | JPMorgan Healthcare Conference |
| 2023-11-27 08:30 am | Q4 2023 Earnings Call |
| 2023-11-27 08:00 am | Q4 2023 Earnings Release |
| 2023-08-08 08:30 am | Q3 2023 Earnings Call |
| 2023-08-08 07:30 am | Q3 2023 Earnings Release |
| 2023-08-07 12:30 pm | BTIG Virtual Biotechnology Conference |
| 2023-06-26 07:00 am | H.C. Wainwright Neuropsychiatry Conference - Fireside Chat |
| 2023-05-22 | Annual General Meeting |
| 2023-05-09 08:30 am | Q2 2023 Earnings Call |
| 2023-05-09 07:30 am | Q2 2023 Earnings Release |
| 2023-05-02 09:30 am | H.C. Wainwright BioConnect Investor Conference - Fireside Chat |
| 2023-04-17 08:00 am | Needham Healthcare Conference |
| 2023-02-07 08:30 am | Q1 2023 Earnings Call |
| 2023-02-07 07:00 am | Q1 2023 Earnings Release |
| 2023-01-12 11:15 am | JP Morgan Healthcare Conference |
| 2022-12-05 08:30 am | ANAVEX®2-73-AD-004 Phase 2b/3 Study Results Call |
Annual results
| Fiscal Period | September | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -51,0 -48,0 -6.22% | -55,8 -57,0 2.18% | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 0,00 - | -31,1 -31,9 2.39% | -42,0 -40,8 -2.88% | -51,0 -48,8 -4.38% | -55,8 -56,6 1.41% | -52,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | -26,3 -29,8 11.86% | -37,6 -36,6 -2.72% | -47,6 -48,1 0.96% | -47,5 -50,7 6.3% | -46,5 |
|
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | -26,3 -29,5 10.81% | -37,9 -37,1 -2.26% | -48,0 -47,8 -0.37% | -47,5 -50,7 6.36% | -46,6 |
|
EPS USD | Released Forecast Spread | -0,54 -0,62 12.9% | -0,45 -0,51 11.76% | -0,54 -0,54 -0.93% | -0,62 -0,62 0% | -0,60 -0,64 5.51% | -0,57 |
| Announcement Date | 16/12/19 | 28/12/20 | 24/11/21 | 28/11/22 | 27/11/23 | - |
Quarterly results
| Fiscal Period | September | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,7 -12,6 6.98% | -11,5 -13,0 11.48% | -12,5 -13,1 4.79% | -15,3 -13,1 -16.7% | -15,4 -15,0 -2.39% | -14,2 -15,0 5.41% | -13,5 -14,0 3.35% | -12,7 -13,0 2.67% | -12,0 | -13,5 | -16,0 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,9 -12,4 12.28% | -10,4 -12,7 17.72% | -12,3 -12,9 4.85% | -14,1 -13,0 -8.25% | -13,0 -15,0 13.44% | -13,1 -14,1 7.4% | -11,2 -13,3 15.5% | -10,2 -12,1 15.61% | -10,6 | -12,4 | -15,0 | |
|
Net income Million USD | Released Forecast Spread | -10,9 -12,6 13.52% | -10,4 -13,0 19.69% | -12,4 -12,8 3.41% | -14,3 -13,4 -6.93% | -13,0 -15,0 13.57% | -13,1 -14,1 7.04% | -11,3 -13,3 15.19% | -10,1 -12,1 16.14% | -10,6 | -12,4 | -15,0 | |
|
EPS USD | Released Forecast Spread | -0,14 -0,16 12.5% | -0,14 -0,17 17.65% | -0,16 -0,17 3.03% | -0,18 -0,17 -5.88% | -0,17 -0,19 10.53% | -0,17 -0,18 5.56% | -0,14 -0,17 17.65% | -0,12 -0,15 20% | -0,11 -0,15 26.67% | -0,13 | -0,15 | -0,18 |
| Announcement Date | 09/02/22 | 10/05/22 | 09/08/22 | 28/11/22 | 07/02/23 | 09/05/23 | 08/08/23 | 27/11/23 | 07/02/24 | - | - | - |
More events
Past sector events for Anavex Life Sciences Corp.
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
| 2024-03-28 04:05 pm | ACELYRIN, INC.: Q4 2023 Earnings Release |
| 2024-03-28 04:02 pm | IMMUNOME, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVXL Stock
- Calendar Anavex Life Sciences Corp.
